APA (7th ed.) Citation

H, L., A, K., P, R., A, P., J, H., D, S., . . . E, W. (2026). First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort. Journal of child neurology, 8830738261452770. https://doi.org/10.1177/08830738261452770

Chicago Style (17th ed.) Citation

H, Lewis, Kiss A, Ramani P, Parkey A, Haire J, Samanta D, Ramakrishnaiah R, and Willis E. "First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort." Journal of Child Neurology 2026: 8830738261452770. https://doi.org/10.1177/08830738261452770.

MLA (9th ed.) Citation

H, Lewis, et al. "First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort." Journal of Child Neurology, 2026, p. 8830738261452770, https://doi.org/10.1177/08830738261452770.